These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 8292635)

  • 1. Drug abuse treatment programs as centers for HIV-related research and treatment.
    Sawyer RC; Brown LS; Bailey J; Hickson M; Lee P; McNair D; Rawls J; Skinner A
    J Addict Dis; 1993; 12(4):121-9. PubMed ID: 8292635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe sex? Misconceptions, gender differences and barriers among injection drug users: a focus group approach.
    Weiss SH; Weston CB; Quirinale J
    AIDS Educ Prev; 1993; 5(4):279-93. PubMed ID: 8297708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with changes in sex behaviour among drug users in Puerto Rico.
    Robles RR; Marrero CA; Matos TD; Colón HM; Finlinson HA; Reyes JC; Sahai H
    AIDS Care; 1998 Jun; 10(3):329-38. PubMed ID: 9828976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of HIV+ and HIV- adolescents: risk factors and psychosocial determinants.
    Hein K; Dell R; Futterman D; Rotheram-Borus MJ; Shaffer N
    Pediatrics; 1995 Jan; 95(1):96-104. PubMed ID: 7770318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk contexts and risk behaviors in the Euregion Maas-Rhein: the Boule de Neige intervention for AIDS prevention among drug users.
    Franken IH; Kaplan CD
    AIDS Educ Prev; 1997 Apr; 9(2):161-80. PubMed ID: 9167801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.
    Avants SK; Margolin A; Usubiaga MH; Doebrick C
    J Subst Abuse Treat; 2004 Mar; 26(2):67-78. PubMed ID: 15050083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
    Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
    Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skills-training groups to reduce HIV transmission and drug use among methadone patients.
    Schilling RF; el-Bassel N; Hadden B; Gilbert L
    Soc Work; 1995 Jan; 40(1):91-101. PubMed ID: 7863377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS knowledge and risk behaviors among culturally diverse women.
    Harrison DF; Wambach KG; Byers JB; Imershein AW; Levine P; Maddox K; Quadagno DM; Fordyce ML; Jones MA
    AIDS Educ Prev; 1991; 3(2):79-89. PubMed ID: 1873140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
    Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
    Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS knowledge and attitudes among injection drug users: the issue of reliability.
    Longshore D; Hsieh SC; Anglin MD
    AIDS Educ Prev; 1992; 4(1):29-40. PubMed ID: 1543642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance abuse treatment and risk behaviors among HIV-infected persons with alcohol problems.
    Palepu A; Raj A; Horton NJ; Tibbetts N; Meli S; Samet JH
    J Subst Abuse Treat; 2005 Jan; 28(1):3-9. PubMed ID: 15723726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social support and sexual risk taking among women on methadone.
    el-Bassel N; Schilling RF
    AIDS Educ Prev; 1994 Dec; 6(6):506-13. PubMed ID: 7702961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users.
    Margolin A; Avants SK; Warburton LA; Hawkins KA; Shi J
    Health Psychol; 2003 Mar; 22(2):223-8. PubMed ID: 12683743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of HIV testing and high-risk behaviors among clients in methadone maintenance treatment.
    Grella CE; Campos M; Anglin MD
    AIDS Educ Prev; 1998 Oct; 10(5):403-16. PubMed ID: 9799937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
    Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-associated medical, behavioral, and psychiatric characteristics of treatment-seeking, methamphetamine-dependent men who have sex with men.
    Peck JA; Shoptaw S; Rotheram-Fuller E; Reback CJ; Bierman B
    J Addict Dis; 2005; 24(3):115-32. PubMed ID: 16186088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users.
    Williams AB; McNelly EA; Williams AE; D'Aquila RT
    AIDS Care; 1992; 4(1):35-41. PubMed ID: 1314099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.